The Medical Letter - 2021
Search or Select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Year:    Publication:      2021 Annual Index: U.S. English | Canadian English
January 11, 2021 (Issue 1615)  
January 25, 2021 (Issue 1616)  
February 8, 2021 (Issue 1617)  
February 22, 2021 (Issue 1618)  
March 8, 2021 (Issue 1619)  
March 22, 2021 (Issue 1620)  
April 5, 2021 (Issue 1621)  
April 19, 2021 (Issue 1622)  
May 3, 2021 (Issue 1623)  
May 17, 2021 (Issue 1624)  
May 31, 2021 (Issue 1625)  
June 14, 2021 (Issue 1626)  
  • Drugs for Chronic Heart Failure   
    Among patients with chronic heart failure, those with a left ventricular ejection fraction (LVEF) ≤40% are considered to have heart failure with reduced ejection fraction (HFrEF). Patients...
June 28, 2021 (Issue 1627)  
July 12, 2021 (Issue 1628)  
  • Aducanumab (Aduhelm) for Alzheimer's Disease   
    Aducanumab-avwa (Aduhelm – Biogen/Eisai), an IV amyloid beta-directed monoclonal antibody, has received accelerated approval from the FDA for treatment of Alzheimer's disease. The...
  • Semaglutide (Wegovy) for Weight Loss   
    The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide, previously approved by the FDA as Ozempic to treat type 2 diabetes and to reduce the risk of major adverse...
  • Insect Repellents   
    The Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) recommend using insect repellents to prevent infections transmitted by mosquitoes and...
July 26, 2021 (Issue 1629)  
August 9, 2021 (Issue 1630)  
August 23, 2021 (Issue 1631)  
September 6, 2021 (Issue 1632)  
September 20, 2021 (Issue 1633)  
October 4, 2021 (Issue 1634)  
October 18, 2021 (Issue 1635)  
November 1, 2021 (Issue 1636)  
November 15, 2021 (Issue 1637)  
November 29, 2021 (Issue 1638)  
December 13, 2021 (Issue 1639)  
December 27, 2021 (Issue 1640)